What You Should Know:
– Sequel Med Tech, a company developing state-of-the-art insulin delivery technologies, announced a commercial development agreement with Abbott.
– The collaboration aims for the future integration of Sequel’s twiist™ Automated Insulin Delivery…
Continue Reading
What You Should Know:
– Abbott, a provider of continuous glucose monitoring (CGM) biowearable technology, has announced a landmark agreement with Epic Systems, a major provider of electronic health records (EHR).
– The first-of-its-kind collaboration for…
Continue Reading
What You Should Know:
– Glooko, a provider of integrated digital health solutions for diabetes management, has announced a significant expansion of its platform’s capabilities with the integration of Abbott’s FreeStyle Libre continuous glucose monitoring…
Continue Reading
What You Should Know:
– Sequel Med Tech, LLC, a company focused on developing cutting-edge insulin delivery technologies, has announced that its innovative twiist™ Automated Insulin Delivery (AID) System, powered by Tidepool, will be the…
Continue Reading
[embedded content]
What You Should Know:
– A recent survey and film conducted by Abbott reveals the significant impact of stigma and misconceptions on people living with diabetes.
– The survey, which polled over 2,600 people with…
Continue Reading
Jim Mercadante, Chief Commercial Officer at Qure.ai
What You Should Know:
– Qure.ai, a global provider of AI-powered healthcare solutions, announced the appointment of Jim Mercadante as its new Chief Commercial Officer.
– Based in New York,…
Continue Reading
Singapore’s Health Promotion Board has partnered with several technology companies to pilot programmes that aim to promote self-health management by delivering data-driven, personalised recommendations for preventing and managing chronic diseases.WHAT IT’S ABOUT
The DigiCoach programme with…
Copyright: Julien Behal
What You Should Know:
– Abbott, a global healthcare leader, has officially opened its new global manufacturing center of excellence for Abbott’s diabetes care business in Kilkenny, Ireland.
– Abbott’s FreeStyle Libre portfolio is…
Continue Reading
Large language models (LLMs) can optimize clinical workflows; however, the economic and computational challenges of their utilization at the health system scale are underexplored. We evaluated how concatenating queries with multiple clinical notes and…
Continue Reading
What You Should Know:
– Abbott announced that its FreeStyle Libre 2 and 3 continuous glucose monitoring (CGM) systems have received FDA clearance for use during common imaging procedures, including X-rays, CT scans, and MRIs.
–…
Continue Reading
